Osaic Holdings
REGN icon

Osaic Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Osaic Holdings’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.75M Buy
12,423
+185
+2% +$126K 0.01% 1214
2026
Q1 		$9.46M Buy
12,238
+439
+4% +$336K 0.01% 954
2025
Q4 		$9.11M Sell
11,799
-2,937
-20% -$1.99M 0.01% 993
2025
Q3 		$8.4M Sell
14,736
-2,332
-14% -$1.32M 0.01% 1125
2025
Q2 		$9.61M Buy
17,068
+6,073
+55% +$3.39M 0.02% 848
2025
Q1 		$6.98M Sell
10,995
-5,242
-32% -$3.61M 0.02% 880
2024
Q4 		$7.51M Buy
16,237
+6,895
+74% +$5.79M 0.02% 814
2024
Q3 		$9.82M Buy
9,342
+1,417
+18% +$1.58M 0.02% 683
2024
Q2 		$8.33M Sell
7,925
-2,374
-23% -$2.3M 0.02% 716
2024
Q1 		$9.91M Sell
10,299
-5,299
-34% -$5.04M 0.02% 694
2023
Q4 		$13.7M Sell
15,598
-2,470
-14% -$2.03M 0.02% 629
2023
Q3 		$14.9M Buy
18,068
+7,711
+74% +$6.06M 0.02% 669
2023
Q2 		$7.44M Sell
10,357
-135
-1% -$104K 0.01% 932
2023
Q1 		$8.62M Sell
10,492
-1,644
-14% -$1.24M 0.02% 833
2022
Q4 		$8.76M Sell
12,136
-3,223
-21% -$2.38M 0.02% 800
2022
Q3 		$10.6M Buy
15,359
+538
+4% +$339K 0.02% 627
2022
Q2 		$8.77M Sell
14,821
-2,691
-15% -$1.75M 0.02% 729
2022
Q1 		$11.6M Sell
17,512
-320
-2% -$202K 0.02% 671
2021
Q4 		$11.3M Buy
17,832
+6,250
+54% +$3.84M 0.02% 674
2021
Q3 		$7M Buy
11,582
+855
+8% +$531K 0.01% 846
2021
Q2 		$5.99M Buy
10,727
+966
+10% +$489K 0.01% 943
2021
Q1 		$4.62M Sell
9,761
-497
-5% -$242K 0.01% 1006
2020
Q4 		$4.95M Sell
10,258
-130
-1% -$70.2K 0.01% 881
2020
Q3 		$5.82M Sell
10,388
-6,192
-37% -$3.75M 0.02% 693
2020
Q2 		$10.3M Sell
16,580
-51,451
-76% -$29.2M 0.03% 427
2020
Q1 		$6.01M Buy
+68,031
New +$28.1M 0.02% 531

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Osaic Holdings's REGN Position: Q2 2026 in Review

Osaic Holdings increased its Regeneron Pharmaceuticals (REGN) stake by 1.5% in Q2 2026, buying an estimated $126K and bringing the position to 12,423 shares worth $7.75M. The position accounts for 0.01% of the portfolio, ranked #1214.

Osaic Holdings first reported a position in REGN in Q1 2020 and has held it in 26 quarters since. The position peaked at $14.9M in Q3 2023. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Osaic Holdings held 12,423 shares of Regeneron Pharmaceuticals worth $7.75M as of Q2 2026.
  • Osaic Holdings bought 185 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $126K.
  • Regeneron Pharmaceuticals made up 0.01% of Osaic Holdings's portfolio in Q2 2026, its #1214 holding.
  • Osaic Holdings first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Regeneron Pharmaceuticals position peaked at $14.9M in Q3 2023.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.